Patents by Inventor Andrew I. Dayton

Andrew I. Dayton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160243214
    Abstract: The present invention discloses the construction of dengue virus subgenomic replicons containing large deletions in the structural region (C-preM-E) of the genome, which replicons are useful as vaccines to protect against dengue virus infection.
    Type: Application
    Filed: October 26, 2015
    Publication date: August 25, 2016
    Inventors: Xiaowu Pang, Andrew I. Dayton, Mingjie Zhang
  • Patent number: 9169297
    Abstract: The present invention discloses the construction of dengue virus subgenomic replicons containing large deletions in the structural region (C-preM-E) of the genome, which replicons are useful as vaccines to protect against dengue virus infection.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: October 27, 2015
    Assignee: The United States of America, as represented by the Secretary, Department of Health & Human Services
    Inventors: Xiaowu Pang, Andrew I. Dayton, Mingjie Zhang
  • Publication number: 20120107358
    Abstract: The present invention discloses the construction of dengue virus subgenomic replicons containing large deletions in the structural region (C-preM-E) of the genome, which replicons are useful as vaccines to protect against dengue virus infection.
    Type: Application
    Filed: September 23, 2011
    Publication date: May 3, 2012
    Applicant: The Government of the USA, as represented by the Secretary, Department of Health & Human Services
    Inventors: Xiaowu Pang, Andrew I. Dayton, Mingjie Zhang
  • Patent number: 8048427
    Abstract: The present invention discloses the construction of dengue virus subgenomic replicons containing large deletions in the structural region (C-preM-E) of the genome, which replicons are useful as vaccines to protect against dengue virus infection.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: November 1, 2011
    Assignee: The United States of America as represented by the Secretary, Department of Health and Human Services
    Inventors: Xiaowu Pang, Andrew I. Dayton, Mingjie Zhang
  • Publication number: 20100233210
    Abstract: The present invention discloses the construction of dengue virus subgenomic replicons containing large deletions in the structural region (C-preM-E) of the genome, which replicons are useful as vaccines to protect against dengue virus infection.
    Type: Application
    Filed: February 27, 2009
    Publication date: September 16, 2010
    Applicants: Department of Health and Human Services
    Inventors: Xiaowu Pang, Andrew I. Dayton, Mingjie Zhang
  • Patent number: 7524508
    Abstract: The present invention discloses the construction of dengue virus subgenomic replicons containing large deletions in the structural region (C-preM-E) of the genome, which replicons are useful as vaccines to protect against dengue virus infection.
    Type: Grant
    Filed: September 5, 2003
    Date of Patent: April 28, 2009
    Assignee: The United states of America as represented by the Department of Health and Human Services
    Inventors: Xiaowu Pang, Andrew I. Dayton, Mingjie Zhang
  • Publication number: 20040265338
    Abstract: The present invention discloses the construction of dengue virus subgenomic replicons containing large deletions in the structural region (C-preM-E) of the genome, which replicons are useful as vaccines to protect against dengue virus infection.
    Type: Application
    Filed: September 5, 2003
    Publication date: December 30, 2004
    Inventors: Xiaowu Pang, Andrew I. Dayton, Mingjie Zhang